{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:12:25Z","timestamp":1788423145646,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,8,30]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Heterocyclic derivatives represent the primary scaffold for numerous medicinal agents of\nutmost importance for humanity. Among them, triazine derivatives, and particularly the s-triazine\nscaffold, have long represented a cornerstone in medicinal chemistry research due to their broad\npharmacological versatility. This heterocyclic system is a key structure in the design of therapeutic\nagents exhibiting antitrypanosomal, antiviral, antimicrobial, anti-inflammatory, antidiabetic, and\nanticancer activities. The s-triazine core represents a privileged scaffold, allowing rational optimization\nthrough targeted substitution patterns at different positions. Indeed, the triazine ring is characterized\nby the replacement of 3 carbon atoms of a benzene ring with three nitrogens, affording three\neasily modified sites at positions 2, 4, and 6, which can be variously substituted to modulate physiological\nand biological activities. In this review, we will focus on the structural and pharmacological\nfeatures of s-triazine-based compounds developed as anticancer agents. Indeed, cancer is an increasing\nworldwide emergency, and its incidence and mortality will double in the next twenty years.\nThus, the development of innovative and powerful anticancer agents remains one of the biggest\nchallenges in the research world.\n\nIn this respect, we provide an overview of the recent primary literature concerning the development\nof s-triazine-based antitumor agents, focusing on the most potent compounds acting on specific molecular\ntargets and discussing the structure-activity relationships (SARs), when available. The aim is\nto provide important principles for the future development of new anticancer agents with greater\npotency against drug-sensitive and drug-resistant cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575477125260820031228","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:36:59Z","timestamp":1788187019000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["s-triazine-based Derivatives as Anticancer Agents"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2378-3292","authenticated-orcid":true,"given":"Doralice","family":"Giorgini","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3294-3626","authenticated-orcid":true,"given":"Jacopo","family":"Castagnoli","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2267-6508","authenticated-orcid":true,"given":"Lorenzo","family":"Filidei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1584","authenticated-orcid":true,"given":"Riccardo","family":"Di Leo","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology,National Research Council of Italy, CNR Research Area, 56124, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6072-4698","authenticated-orcid":true,"given":"Silvia","family":"Salerno","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7897-7917","authenticated-orcid":true,"given":"Federico","family":"Da Settimo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2567-3637","authenticated-orcid":true,"given":"Tiziano","family":"Marzo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-7195","authenticated-orcid":true,"given":"Elisabetta","family":"Barresi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-4052","authenticated-orcid":true,"given":"Emma","family":"Baglini","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology,National Research Council of Italy, CNR Research Area, 56124, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-939X","authenticated-orcid":true,"given":"Sabrina","family":"Taliani","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575477125260820031228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/257806\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575477125260820031228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:14:37Z","timestamp":1788419677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/257806\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575477125260820031228","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}